Sectors

Capital One has led a round that included Citi Ventures, increasing the ticket and hotel booking portal's overall funding to $435m.

The spinout of Yamaguchi University and National Cancer Centre Japan has raised the cash from investors including Dai-ichi Life and Binex.

Hanwha and SoftBank could exit the advanced biomaterials developer in the offering, which will follow more than $870m in funding.

The Cigna and Kaiser Permanente-backed mental healthcare app developer took its total funding to $220m in a round valuing it at about $1bn.

BioLife Solutions will issue more than 6.6 million shares to acquire Ohio University-affiliated Stirling Ultracold in an all-stock transaction.

The Paypal and Citi-backed payment platform developer has secured an additional $90m following a $180m close in January.

Main Sequence Ventures has thrown its weight behind Nourish’s $11m funding round, which was co-led by Horizon Ventures.

Retinal disease drug developer Gyroscope Therapeutics has raised series C funding from investors including Fosun Pharma.

Cambridge Innovation Capital has returned for a series C round for University of Cambridge-linked Gyroscope Therapeutics, which also welcomed back Syncona.

The solid tumour therapy developer secured $21.9m from investors including Dai-ichi Life, Binex, Bigen and Shibuya Kogyo.

The open-source software manager was valued above $800m in a round that included new corporate backer Salesforce Ventures.